Ebglyss and Dupixent are used to treat moderate to severe atopic dermatitis in certain children. Dupixent is used in children ages 6 months and older. Ebglyss is used in children ages 12 years and ...

Studies show that there are few if any, additional side effects from the COVID-19 vaccine for people with eczema. In one ...

Sanofi’s Dupixent (dupilumab) has been cleared for NHS funding in Wales and Scotland in adolescents with severe eczema, also known as atopic dermatitis. The decisions from the All Wales ...

Dupixent (dupilumab) is a brand-name subcutaneous injection that’s prescribed for atopic dermatitis, asthma, and more. It works to treat those conditions by blocking proteins that cause ...

An estimated 16.5 million Americans have eczema, per Lilly. Ebyglyss enters a category in which Dupixent, from Sanofi and Regeneron, has been on the market – and advertising – since its FDA ...